Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$1.38 - $2.42 $20,494 - $35,939
-14,851 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$1.27 - $1.62 $18,860 - $24,058
14,851 New
14,851 $22,000

Others Institutions Holding MITO

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0

About Stealth BioTherapeutics Corp


  • Ticker MITO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,548,600
  • Description
  • Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duche...
More about MITO
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.